Horizon Technology Finance Provides Third Quarter 2023 Portfolio Update
- Horizon Platform originated $88.9 million of new loans in Q3
- Committed backlog of the Horizon Platform's debt investments increased to $222 million
- HRZN received $38 million in loan payoffs and partial paydowns in Q3
- HRZN closed new loan commitments totaling $157.7 million in Q3
- None.
- Horizon Platform Originates
- Horizon Platform Ends Quarter with Committed Backlog of
"We continued to opportunistically and selectively add high-quality investments to our portfolio, as the Horizon Platform originated
Third Quarter 2023 Portfolio Update
Originations
During the third quarter of 2023, a total of
to a new portfolio company, Elligo Health Research, Inc., a developer of a technology platform, which empowers clients to seamlessly utilize non-traditional clinical trial sites, significantly increasing clients' access to untapped trial participants.$25.0 million to a new portfolio company, Mirantis, Inc., a builder and manager of open cloud software infrastructure, enabling enterprises across a wide range of industries to ship code more rapidly.$20.0 million to an existing portfolio company, Sonex Health, Inc., a developer of technology, education and training programs for ultrasound guided procedures.$15.0 million to an existing portfolio company, BriteCore Holdings, Inc., a developer of a cloud-native software platform for the property and casualty insurance segment, in connection with the prepayment of its existing Horizon Platform loan facility and providing it with additional debt capital.$12.5 million to a new portfolio company, a developer of innovative, affordable and non-invasive treatments for hyperhidrosis, or excessive sweating.$10.0 million to a new portfolio company, Tallac Therapeutics, Inc., a developer of multiple novel immunotherapies to fight cancer.$5.0 million to an existing portfolio company, Nexii Building Solutions Inc., a green construction technology company focused on creating environmentally-friendly, durable, cost-efficient and disaster-resilient buildings.$0.7 million to an existing portfolio company, Aerobiotix, LLC, a manufacturer of air disinfection systems for medical, healthcare and community facilities that eliminate airborne pathogens to optimize indoor air quality.$0.2 million
In addition, HRZN funded
Liquidity Events and Partial Paydowns
HRZN experienced liquidity events from five portfolio companies in the third quarter of 2023, including principal prepayments and partial paydowns of
- In July, HRZN received a partial paydown of
on its venture loans to Evelo Biosciences, Inc. ("Evelo"), and HRZN and Evelo converted an additional$5.0 million of the principal amount of the outstanding venture loans into shares of common stock of Evelo. HRZN also holds warrants in Evelo.$5.0 million - In July, HRZN received
in proceeds in connection with the redemption of warrants in Corvium, Inc.$0.02 million - In August, with the proceeds of a new loan from the Horizon Platform, Sonex Health, Inc. ("Sonex") prepaid its previously outstanding principal balance of
on its venture loan facility, plus interest and end-of-term payment. HRZN continues to hold warrants in Sonex.$12.5 million - In September, Avalo Therapeutics, Inc. ("Avalo") paid its outstanding principal balance of
on its venture loan, plus interest and end-of-term payment. HRZN continues to hold warrants in Avalo.$10.4 million - In September, with the proceeds of a new loan from HRZN, BriteCore Holdings, Inc. ("BriteCore") prepaid its previously outstanding principal balance of
on its venture loan facility, plus interest and end-of-term payment. HRZN continues to hold warrants in BriteCore.$10.0 million
In addition, in July, HRZN converted
Principal Payments Received
During the third quarter of 2023, HRZN received regularly scheduled principal payments on investments totaling
Commitments
During the quarter ended September 30, 2023, HRZN closed new loan commitments totaling
Pipeline and Term Sheets
As of September 30, 2023, HRZN's unfunded loan approvals and commitments ("Committed Backlog") were
Warrant and Equity Portfolio
As of September 30, 2023, HRZN held a portfolio of warrant and equity positions in 100 portfolio companies, including 86 private companies, which provides the potential for future additional returns to HRZN's shareholders.
About Horizon Technology Finance
Horizon Technology Finance Corporation (NASDAQ: HRZN), externally managed by Horizon Technology Finance Management LLC, an affiliate of Monroe Capital, is a leading specialty finance company that provides capital in the form of secured loans to venture capital backed companies in the technology, life science, healthcare information and services, and sustainability industries. The investment objective of Horizon is to maximize its investment portfolio's return by generating current income from the debt investments it makes and capital appreciation from the warrants it receives when making such debt investments. Horizon is headquartered in
Forward-Looking Statements
Statements included herein may constitute "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Statements other than statements of historical facts included in this press release may constitute forward-looking statements and are not guarantees of future performance, condition or results and involve a number of risks and uncertainties. Actual results may differ materially from those in the forward-looking statements as a result of a number of factors, including those described from time to time in the Company's filings with the Securities and Exchange Commission. Horizon undertakes no duty to update any forward-looking statement made herein. All forward-looking statements speak only as of the date of this press release.
Contacts:
Investor Relations:
ICR
Garrett Edson
ir@horizontechfinance.com
(860) 284-6450
Media Relations:
ICR
Chris Gillick
HorizonPR@icrinc.com
(646) 677-1819
View original content:https://www.prnewswire.com/news-releases/horizon-technology-finance-provides-third-quarter-2023-portfolio-update-301954061.html
SOURCE Horizon Technology Finance Corporation
FAQ
What is the total amount of new loans originated by Horizon Platform in Q3 2023?
What is the committed backlog of the Horizon Platform's debt investments at the end of Q3 2023?
How much did HRZN receive in loan payoffs and partial paydowns in Q3 2023?